Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 27.60B | 27.57B | 26.32B | 26.17B | 20.23B | 19.23B |
Gross Profit | 5.59B | 5.42B | 5.28B | 5.01B | 3.46B | 3.67B |
EBITDA | 3.98B | 3.63B | 3.89B | 3.26B | 2.12B | 1.84B |
Net Income | 1.69B | 1.51B | 1.77B | 1.30B | 521.26M | 288.41M |
Balance Sheet | ||||||
Total Assets | 31.93B | 31.03B | 29.48B | 25.94B | 24.70B | 23.14B |
Cash, Cash Equivalents and Short-Term Investments | 10.85B | 10.37B | 10.26B | 8.76B | 7.97B | 8.11B |
Total Debt | 5.79B | 6.65B | 5.25B | 4.86B | 5.28B | 6.08B |
Total Liabilities | 11.66B | 11.72B | 10.57B | 9.72B | 10.17B | 10.39B |
Stockholders Equity | 19.18B | 18.37B | 17.96B | 15.34B | 13.74B | 12.01B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -388.72M | 1.06B | 1.21B | 99.29M | 1.08B |
Operating Cash Flow | 0.00 | 2.27B | 3.86B | 2.59B | 1.43B | 1.99B |
Investing Cash Flow | 0.00 | -2.50B | -4.00B | -918.48M | -1.23B | -1.59B |
Financing Cash Flow | 0.00 | 379.51M | -237.03M | -746.61M | -1.04B | -175.13M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥10.92B | 7.10 | 9.68% | 4.78% | -14.42% | ||
75 Outperform | ¥9.57B | 23.84 | 6.07% | -2.94% | -52.90% | ||
73 Outperform | ¥8.46B | 4.07 | 5.36% | 1.75% | 29.95% | ||
68 Neutral | ¥13.19B | 17.76 | 1.72% | 0.69% | -25.68% | ||
67 Neutral | ¥10.70B | 10.55 | 2.64% | 13.97% | 195.21% | ||
62 Neutral | ¥9.00B | 19.51 | 5.36% | 6.48% | 275.25% | ||
50 Neutral | C$2.90B | 1.80 | -63.12% | 2.50% | 11.24% | -12.42% |